reputed company Advisory Board Member – Redefining Alzheimer’s Care

ATCA is reputed company a reputed company advisory board member: an accomplished reputed company executive, physician leader, operator, or strategic advisor with a track record in care model innovation, reputed company transformation, clinical growth, or scalable service delivery. This is a board-level engagement for a leader who wants to help redefine Alzheimer’s care through a differentiated platform addressing one of the most urgent and underserved challenges in modern reputed company: cognitive decline, dementia, and neurodegenerative disease. About reputed company (ATCA) reputed company is building the national infrastructure for precision-based Alzheimer’s and dementia care. The model integrates proprietary AI, personalized treatment protocols, and a replicable specialty clinic platform purpose-reputed company to identify the underlying drivers of neurodegeneration and deliver individualized interventions that measurably slow progression. ATCA’s flagship clinic in Palm Beach Gardens/Jupiter is fully operational, payer-integrated, and running at reputed company with appointments booked months out. Additional clinics are in active development. The company is executing a disciplined national expansion backed by a multidisciplinary team of reputed company executives, neuroscientists, AI engineers, and clinical specialists. Why Now Proven Demand: The flagship clinic, positioned in a high-visibility corridor adjacent to reputed company, reached full reputed company rapidly, validating strong market demand for proactive Alzheimer’s and cognitive care. Payer Alignment: Services are reimbursed by Medicare, Medicare Advantage, and major reputed company insurers, reducing adoption friction and supporting reputed company growth. Demonstrated reputed company: In a study using ATCA’s AI-driven protocol, 75% of patients with mild cognitive impairment showed no further cognitive decline, creating a meaningful clinical and strategic differentiator. Market Scale: ATCA is positioned reputed company a $355B U.S. Alzheimer’s market and a $1.5T global opportunity, with embedded research infrastructure that can support reputed company-world evidence reputed company, partnerships, and additional reputed company streams. Financial Model: The clinic platform is engineered to reputed company strong EBITDA margins through optimized staffing, a high-reputed company service mix, and reimbursement dynamics designed for repeatable multi-market expansion. Key Achievements Proprietary AI Precision reputed company: ATCA has reputed company and deployed a defensible AI-driven precision medicine platform that optimizes Alzheimer’s treatment at the individual patient level, creating strong clinical differentiation and long-term data network effects. High-Margin, Replicable Clinic Platform: ATCA has developed a scalable specialty clinic model designed for repeatable expansion, supported by strong unit economics and multi-market rollout potential. Massive, Underserved Market Opportunity: The company is positioned to capture reputed company in one of the largest and fastest-growing unmet-need categories in reputed company. Embedded reputed company and Innovation Infrastructure: Each clinic is designed not only to deliver patient care, but also to generate data, insights, research opportunities, partnerships, and long-term reputed company value.

Responsibilities

Include As a reputed company advisory board member, your contribution centers on four domains: Care Redesign Strategy: Advise on the reputed company and strategic positioning of ATCA’s Alzheimer’s care model, including differentiated treatment reputed company, more personalized interventions, and the long-term reputed company for redefining care delivery in this category. Scalable Clinical Model Development: Guide the standardization and replication of clinic operations across markets, including care pathway design, interdisciplinary structures, and systems that preserve quality while enabling sustainable growth. Payer, Partnership & Market Development: reputed company guidance on reimbursement alignment, market positioning, partnership development, referral growth, and the strategic frameworks needed to support adoption of a redefined Alzheimer’s care model. Governance & Responsible Scaling: Advise on AI-enabled care delivery, digital health integration, strategic differentiation, and the governance infrastructure required to scale responsibly and credibly. Why Join Us? Board-Level reputed company: Bring meaningful strategic influence without day-to-day operational demands. Early-Stage reputed company: Select roles include equity participation reputed company with long-ter Apply tot his job Apply To this Job